862
Miniaturization and Biocompatible Encapsulation for Implantable Biomedical Silicon Devices
The objective of this paper is to present new strategy of packaging developed in the CEA-LETI for medical applications which include a Micro Electro-Mechanical Systems (MEMS) accelerometer and an Application-Specific Integrated Circuit (ASIC) inside a hermetic silicon box that could be embedded in a cardiac lead in order to monitor the endocardial acceleration (fig1).
The electronic components are bonded on a wafer silicon interposer and covered by an additional silicon wafer which contain cavities. The wafer bonding is performed at the wafer level using eutectic AuSi solder. The gas content and hermeticity of the package were analyzed using Residual Gas Analysis (RGA) and the standard leak rate, which is assessed based on the formation of water droplet condensation in our package after 20 years, was estimated to ~6 10-13 atm.cc/s which guarantees a life time much more than 20 years.
The final silicon box is encapsulated with biocompatible materials that have high conformality deposition and act as good bi-directional barrier. Materials that had been reported in literature as biocompatible and compatible with fabrication in standard clean rooms were studied. These include Al2O3, BN, SiC, DLC(a-CH), HfO2, SiN, SiO2, SiOC, TiO2 and ZnO. Biodegradation tests were performed in phosphate buffer saline at different temperature. Changes in thickness and chemical composition were monitored by variable angle spectroscopic ellipsometry and x-ray photon electron spectroscopy. Non-cytotoxic test according to in-vitro tests outlined by the norm ISO10993-5 were carried out. Finally, Helium gas permeability measurements of selected packaging layers are also provided.